Cargando…
New Oral Drugs for Migraine
Migraine is a common and disabling neurological disorder, with several manifestations, of which pain is just one. Despite its worldwide prevalence, there remains a paucity of targeted and effective treatments for the condition, leaving many of those affected underserved by available treatments. Work...
Autores principales: | Karsan, Nazia, Goadsby, Peter J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9477894/ https://www.ncbi.nlm.nih.gov/pubmed/36031682 http://dx.doi.org/10.1007/s40263-022-00948-8 |
Ejemplares similares
-
Genetic Mechanisms of Migraine: Insights from Monogenic Migraine Mutations
por: Gosalia, Helin, et al.
Publicado: (2023) -
Neuroimaging in the pre-ictal or premonitory phase of migraine: a narrative review
por: Karsan, Nazia, et al.
Publicado: (2023) -
Imaging the Premonitory Phase of Migraine
por: Karsan, Nazia, et al.
Publicado: (2020) -
Molecular Mechanisms of Migraine: Nitric Oxide Synthase and Neuropeptides
por: Karsan, Nazia, et al.
Publicado: (2023) -
Cranial autonomic symptoms: prevalence, phenotype and laterality in migraine and two potentially new symptoms
por: Karsan, Nazia, et al.
Publicado: (2022)